POETIC
Showing 1 - 11 of 11
Breast Cancer Female Trial in United Kingdom (Abemaciclib, Endocrine therapy)
Recruiting
- Breast Cancer Female
- Abemaciclib
- Endocrine therapy (letrozole, anastrozole, exemestane or tamoxifen)
-
Truro, Cornwall, United Kingdom
- +43 more
Jan 23, 2023
Overweight and Obesity Among Established Cardiovascular Disease.
Not yet recruiting
- Obesity
- Overweight
- No treatment given
-
Plainsboro, New Jersey
- +4 more
May 15, 2023
Relapsed T-Cell Acute Lymphoblastic Leukemia, Relapsed T-Cell Lymphoblastic Lymphoma Trial in Worldwide (Nelarabine, Etoposide,
Terminated
- Relapsed T-Cell Acute Lymphoblastic Leukemia
- Relapsed T-Cell Lymphoblastic Lymphoma
- Nelarabine
- +4 more
-
Los Angeles, California
- +36 more
Sep 8, 2020
COVID-19 Trial in Calgary (Physiotherapy)
Not yet recruiting
- COVID-19
- Physiotherapy
-
Calgary, Alberta, Canada
- +1 more
Sep 8, 2021
Post-traumatic Stress Trial in Toulouse (Post traumatic stress disorder questionnaire)
Recruiting
- Post-traumatic Stress
- Post traumatic stress disorder questionnaire
-
Toulouse, FranceCHU Toulouse
Mar 12, 2021
Relapsed/Refractory AML, Relapsed/Refractory ALL, Secondary AML/MDS Trial in Canada, United States (Plerixafor Dose Escalation)
Completed
- Relapsed/Refractory AML
- +5 more
- Plerixafor Dose Escalation
-
Phoenix, Arizona
- +8 more
Sep 5, 2018
Brain Cancer Trial in Canada, United States (cetuximab in conjunction with external beam radiation therapy, followed by
Completed
- Brain Cancer
- cetuximab in conjunction with external beam radiation therapy, followed by cetuximab and irinotecan
-
Phoenix, Arizona
- +11 more
Mar 2, 2022
Breast Cancer Trial in United Kingdom (Aromatase Inhibitors)
Active, not recruiting
- Breast Cancer
- Aromatase Inhibitors
-
Dundonald, Belfast, United Kingdom
- +127 more
Feb 13, 2020
Neuroblastoma, Sarcoma Trial in Canada, United States (Cyclophosphamide, Topotecan, and Bevacizumab)
Completed
- Neuroblastoma
- Sarcoma
- Cyclophosphamide, Topotecan, and Bevacizumab
-
Phoenix, Arizona
- +6 more
Oct 28, 2019
Breast Cancer Trial in Manchester (biological, drug, other, procedure)
Active, not recruiting
- Breast Cancer
- trastuzumab
- +5 more
-
Manchester, England, United KingdomWythenshawe Hospital
Sep 13, 2018
Resilience Trial in Durham (6-week Writing to Heal course)
Completed
- Resilience
- 6-week Writing to Heal course
-
Durham, North CarolinaDuke Integrative Medicine
Mar 8, 2019